{
    "meta": {
        "found": 4,
        "returned": 4,
        "limit": 10,
        "page": 1
    },
    "data": [
        {
            "uuid": "a2431897-9b04-49f8-b319-eeb1f279d078",
            "title": "iNtRON identifies Prophage and Jamphage in the Pancreatic cancer related Microbiome",
            "description": "/PRNewswire/ -- iNtRON Biotechnology (\"iNtRON\", www.intodeworld.com) has announced today the identification of Prophage and (non-) ORF-Jamphage from the...",
            "keywords": "iNtRON Biotechnology, Inc.",
            "snippet": "It was confirmed the presence of Prophage and Jamphage in the Alkalihalobacillus clausii\n\nProphage and Jamphage are expected to play a substantial role in bacte...",
            "url": "https://www.prnewswire.com/news-releases/intron-identifies-prophage-and-jamphage-in-the-pancreatic-cancer-related-microbiome-301836795.html",
            "image_url": "https://www.prnewswire.com/content/dam/prnewswire/icons/2019-Q4-PRN-Icon-32-32.png",
            "language": "en",
            "published_at": "2023-05-30T02:15:00.000000Z",
            "source": "prnewswire.com",
            "relevance_score": null,
            "entities": [
                {
                    "symbol": "048530.KQ",
                    "name": "iNtRON Biotechnology, Inc.",
                    "exchange": "KOSDAQ",
                    "exchange_long": "KOSDAQ Stock Exchange",
                    "country": "kr",
                    "type": "equity",
                    "industry": "Healthcare",
                    "match_score": 56.858715,
                    "sentiment_score": -0.121233,
                    "highlights": [
                        {
                            "highlight": "BOSTON and SEOUL, South Korea, May 29, 2023 /PRNewswire/ -- <em>iNtRON</em> <em>Biotechnology</em> (\"iNtRON\", www.intodeworld.com) has announced today the identification of Prophage and (non-) ORF-Jamphage from the microbiome frequently observed in long-term Pancreatic cancer survivors.",
                            "sentiment": -0.6597,
                            "highlighted_in": "main_text"
                        },
                        {
                            "highlight": "About <em>iNtRON</em> <em>Biotechnology</em>, <em>Inc</em>.\n\niNtRON (www.iNtODEWORLD.com) is a bio-new drug developing venture company and a leader in bacteriophage-based technology for human with aim to develop and investigate into the 'Immune & Immunotherapeutics' market.",
                            "sentiment": 0.296,
                            "highlighted_in": "main_text"
                        },
                        {
                            "highlight": "SOURCE <em>iNtRON</em> <em>Biotechnology</em>, <em>Inc</em>.",
                            "sentiment": 0,
                            "highlighted_in": "main_text"
                        }
                    ]
                }
            ],
            "similar": []
        },
        {
            "uuid": "5fa196e3-190d-4b26-b232-87584153b0de",
            "title": "Global Microbiome Sequencing Services Market Report 2023: High Cost of Advanced Infrastructure for Sequencing Fuels the Sector",
            "description": "/PRNewswire/ -- The \"Global Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing,...",
            "keywords": "Research and Markets",
            "snippet": "DUBLIN, May 29, 2023 /PRNewswire/ -- The \"Global Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (A...",
            "url": "https://www.prnewswire.com/news-releases/global-microbiome-sequencing-services-market-report-2023-high-cost-of-advanced-infrastructure-for-sequencing-fuels-the-sector-301836654.html",
            "image_url": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "language": "en",
            "published_at": "2023-05-30T00:30:00.000000Z",
            "source": "prnewswire.com",
            "relevance_score": null,
            "entities": [
                {
                    "symbol": "038290.KQ",
                    "name": "Macrogen, Inc.",
                    "exchange": "KOSDAQ",
                    "exchange_long": "KOSDAQ Stock Exchange",
                    "country": "kr",
                    "type": "equity",
                    "industry": "Healthcare",
                    "match_score": 27.999668,
                    "sentiment_score": 0,
                    "highlights": [
                        {
                            "highlight": "., Ltd. ( China )\n\n) EzBiome (US)\n\nBoster Biological Technology (US)\n\nZifo ( India )\n\n) omics2view.consulting GbR ( Germany )\n\n) <em>Macrogen</em>, <em>Inc</em>. ( South Korea )\n\nFor more information about this report visit https://www.researchandmarkets.com/r/emdmrj\n\nAbout ResearchAndMarkets.com\n\nResearchAndMarkets.com is the world's leading source for international",
                            "sentiment": 0,
                            "highlighted_in": "main_text"
                        }
                    ]
                }
            ],
            "similar": []
        },
        {
            "uuid": "bfec5a85-f65e-4599-9c24-e5e277e9f607",
            "title": "Bridge Biotherapeutics to Present at the 2023 BIO International Convention",
            "description": "/PRNewswire/ -- Bridge Biotherapeutics Inc. (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer,...",
            "keywords": "Bridge Biotherapeutics, Inc.",
            "snippet": "SEONGNAM, South Korea and CAMBRIDGE, Mass., May 29, 2023 /PRNewswire/ -- Bridge Biotherapeutics Inc. (KQ288330), a South Korean clinical-stage biotechnology com...",
            "url": "https://www.prnewswire.com/news-releases/bridge-biotherapeutics-to-present-at-the-2023-bio-international-convention-301836576.html",
            "image_url": "https://www.prnewswire.com/content/dam/prnewswire/icons/2019-Q4-PRN-Icon-32-32.png",
            "language": "en",
            "published_at": "2023-05-29T22:00:00.000000Z",
            "source": "prnewswire.com",
            "relevance_score": null,
            "entities": [
                {
                    "symbol": "288330.KQ",
                    "name": "Bridge Biotherapeutics, Inc.",
                    "exchange": "KOSDAQ",
                    "exchange_long": "KOSDAQ Stock Exchange",
                    "country": "kr",
                    "type": "equity",
                    "industry": "N/A",
                    "match_score": 91.72023,
                    "sentiment_score": 0.215533,
                    "highlights": [
                        {
                            "highlight": "., May 29, 2023 /PRNewswire/ -- <em>Bridge</em> <em>Biotherapeutics</em> <em>Inc</em>.",
                            "sentiment": 0,
                            "highlighted_in": "main_text"
                        },
                        {
                            "highlight": "We look forward to advancing our novel research and development pipeline with a strong focus on oncology and pulmonology,\" stated Pavel Printsev, Director of Business Development of <em>Bridge</em> <em>Biotherapeutics</em>.\n\nTo learn more about this session, please visit the events page on our website at https://bit.ly/3lEGVDY.",
                            "sentiment": 0.6808,
                            "highlighted_in": "main_text"
                        },
                        {
                            "highlight": "Date & Time: Tuesday, June 6th, 2023 , 3:15 PM (ET)\n\n, Place: Room 104B\n\nRoom Therapeutic category: Multiple Therapeutics\n\nAbout <em>Bridge</em> <em>Biotherapeutics</em>\n\n<em>Bridge</em> <em>Biotherapeutics</em> <em>Inc</em>., based in the Republic of Korea and the U.S., is a publicly-traded, clinical-stage biotech company founded in 2015.",
                            "sentiment": 0,
                            "highlighted_in": "main_text"
                        },
                        {
                            "highlight": "<em>Bridge</em> <em>Biotherapeutics</em> is engaged in the discovery and development of novel therapeutics, focusing on therapeutic areas with high unmet needs, including ulcerative colitis, fibrotic diseases, and cancers.",
                            "sentiment": 0.6124,
                            "highlighted_in": "main_text"
                        },
                        {
                            "highlight": "SOURCE <em>Bridge</em> <em>Biotherapeutics</em>, <em>Inc</em>.",
                            "sentiment": 0,
                            "highlighted_in": "main_text"
                        },
                        {
                            "highlight": "<em>Bridge</em> <em>Biotherapeutics</em> to Present at the 2023 BIO International Convention",
                            "sentiment": 0,
                            "highlighted_in": "title"
                        }
                    ]
                }
            ],
            "similar": []
        },
        {
            "uuid": "ce3d8a37-05c5-47ec-a4e7-aa17893c34dc",
            "title": "Micro Light-Emitting Diode (LED) Market size to grow by USD 11,716.23 million from 2022 to 2027, Increasing investments in MicroLEDs to drive market growth - Technavio",
            "description": "/PRNewswire/ -- The micro light-emitting diode (LED) market size is estimated to increase by USD 11,716.23 million from 2022 to 2027, with an over CAGR of...",
            "keywords": "Technavio",
            "snippet": "NEW YORK, May 29, 2023 /PRNewswire/ -- The micro light-emitting diode (LED) market size is estimated to increase by USD 11,716.23 million from 2022 to 2027, wit...",
            "url": "https://www.prnewswire.com/news-releases/micro-light-emitting-diode-led-market-size-to-grow-by-usd-11-716-23-million-from-2022-to-2027--increasing-investments-in-microleds-to-drive-market-growth---technavio-301835807.html",
            "image_url": "https://mma.prnewswire.com/media/2086682/technavio_report.jpg?p=facebook",
            "language": "en",
            "published_at": "2023-05-29T19:45:00.000000Z",
            "source": "prnewswire.com",
            "relevance_score": null,
            "entities": [
                {
                    "symbol": "038060.KQ",
                    "name": "Lumens Co., Ltd.",
                    "exchange": "KOSDAQ",
                    "exchange_long": "KOSDAQ Stock Exchange",
                    "country": "kr",
                    "type": "equity",
                    "industry": "Technology",
                    "match_score": 16.106651,
                    "sentiment_score": 0,
                    "highlights": [
                        {
                            "highlight": "., <em>Lumens</em> <em>Co</em>. <em>Ltd</em>, Nanosys Inc., Optovate Ltd., OSRAM GmbH, PlayNitride Inc., Plessey Semiconductors Ltd., Rohinni LLC, Samsung Electronics Co. Ltd., Sony Group Corp., and VueReal Inc.",
                            "sentiment": 0,
                            "highlighted_in": "main_text"
                        },
                        {
                            "highlight": "Ltd., eLux Inc., EPISTAR Corp, Innolux Corp., JBD Inc., LG Electronics Inc., <em>Lumens</em> <em>Co</em>. <em>Ltd</em>, Nanosys Inc., Optovate Ltd., OSRAM GmbH, PlayNitride Inc., Plessey Semiconductors Ltd., Rohinni LLC, Samsung Electronics Co. Ltd., Sony Group Corp., and VueReal Inc.",
                            "sentiment": 0,
                            "highlighted_in": "main_text"
                        }
                    ]
                }
            ],
            "similar": []
        }
    ]
}
                                    
                                

                                    
                                        {
    "meta": {
        "returned": 1,
        "limit": 10
    },
    "data": [
        {
            "key": "KOSDAQ",
            "total_documents": 4,
            "sentiment_avg": 0.02357500046491623
        }
    ]
}